Santaolalla A - Search Results

1

Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial.

Zylstra J, Whyte GP, Beckmann K, Pate J, Santaolalla A, Gervais-Andre L, Russell B, Maisey N, Waters J, Tham G, Lagergren J, Green M, Kelly M, Baker C, Van Hemelrijck M, Goh V, Gossage J, Browning M, Davies A. Zylstra J, et al. Among authors: santaolalla a. Br J Sports Med. 2022 Apr;56(7):402-409. doi: 10.1136/bjsports-2021-104243. Epub 2022 Feb 1. Br J Sports Med. 2022. PMID: 35105604 Clinical Trial.

2

Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study.

Bosco C, Wulaningsih W, Melvin J, Santaolalla A, De Piano M, Arthur R, Van Hemelrijck M. Bosco C, et al. Among authors: santaolalla a. Ecancermedicalscience. 2015 Jul 23;9:555. doi: 10.3332/ecancer.2015.555. eCollection 2015. Ecancermedicalscience. 2015. PMID: 26284119 Free PMC article.

3

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.

Crawley D, Chandra A, Loda M, Gillett C, Cathcart P, Challacombe B, Cook G, Cahill D, Santa Olalla A, Cahill F, George G, Rudman S, Van Hemelrijck M. Crawley D, et al. BMC Cancer. 2017 Jul 21;17(1):494. doi: 10.1186/s12885-017-3458-3. BMC Cancer. 2017. PMID: 28732480 Free PMC article. Clinical Trial.

4

Real World Evidence: A Quantitative and Qualitative Glance at Participant Feedback from a Free-Response Survey Investigating Experiences of a Structured Exercise Intervention for Men with Prostate Cancer.

Fox L, Cahill F, Burgess C, Peat N, Rudman S, Kinsella J, Cahill D, George G, Santaolalla A, Van Hemelrijck M. Fox L, et al. Among authors: santaolalla a. Biomed Res Int. 2017;2017:3507124. doi: 10.1155/2017/3507124. Epub 2017 Jul 3. Biomed Res Int. 2017. PMID: 28758113 Free PMC article.

5

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer.

Nowinski S, Santaolalla A, O'Leary B, Loda M, Mirchandani A, Emberton M, Van Hemelrijck M, Grigoriadis A. Nowinski S, et al. Among authors: santaolalla a. Oncotarget. 2018 Feb 5;9(16):12812-12824. doi: 10.18632/oncotarget.24400. eCollection 2018 Feb 27. Oncotarget. 2018. PMID: 29560112 Free PMC article.

6

Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.

Essén A, Santaolalla A, Garmo H, Hammar N, Walldius G, Jungner I, Malmström H, Holmberg L, Van Hemelrijck M. Essén A, et al. Among authors: santaolalla a. Cancer Causes Control. 2019 Jun;30(6):603-615. doi: 10.1007/s10552-019-01170-6. Epub 2019 Apr 24. Cancer Causes Control. 2019. PMID: 31020446

7

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis.

Santaolalla A, Garmo H, Grigoriadis A, Ghuman S, Hammar N, Jungner I, Walldius G, Lambe M, Holmberg L, Van Hemelrijck M. Santaolalla A, et al. BMC Mol Cell Biol. 2019 Jul 23;20(1):28. doi: 10.1186/s12860-019-0210-7. BMC Mol Cell Biol. 2019. PMID: 31337337 Free PMC article.

8

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.

Sollie S, Michaud DS, Sarker D, Karagiannis SN, Josephs DH, Hammar N, Santaolalla A, Walldius G, Garmo H, Holmberg L, Jungner I, Van Hemelrijck M. Sollie S, et al. Among authors: santaolalla a. BMC Cancer. 2019 Aug 29;19(1):858. doi: 10.1186/s12885-019-6082-6. BMC Cancer. 2019. PMID: 31464604 Free PMC article.

9

Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancer.

Wylie H, Cahill F, Santaolalla A, Moss CL, Enting D, Amery S, Chatterton K, Khan MS, Bryan RT, Gillett C, Josephs D, Chowdhury S, Rudman S, Hughes S, Relton C, Van Hemelrijck M. Wylie H, et al. Among authors: santaolalla a. BMJ Open. 2019 Sep 26;9(9):e029468. doi: 10.1136/bmjopen-2019-029468. BMJ Open. 2019. PMID: 31558452 Free PMC article.

10

Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.

Kalapara AA, Verbeek JFM, Nieboer D, Fahey M, Gnanapragasam V, Van Hemelrijck M, Lee LS, Bangma CH, Steyerberg EW, Harkin T, Helleman J, Roobol MJ, Frydenberg M; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Kalapara AA, et al. Eur Urol Oncol. 2020 Feb;3(1):80-91. doi: 10.1016/j.euo.2019.08.014. Epub 2019 Sep 26. Eur Urol Oncol. 2020. PMID: 31564531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters